Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2022 Filed Sep 9, 2022 20:14 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 824 | $220.08 | $181,345.92 |
DisclosureSEC source: 0000899243-22-030727 · doc4.xml · nonDerivative · entry 2 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,843 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021. F2 · price: $220.08 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.42 to $220.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 08, 2022 Filed Sep 9, 2022 20:14 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 10,000 | $33.87 | $338,700.00 |
DisclosureSEC source: 0000899243-22-030727 · doc4.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC |
Snodgres JonChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 970 | $0.00 Strike: $215.58 | $0.00 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · derivative · entry 6 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,940 Underlying: Common Stock · 970 shares Expires 2031-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares vest and become exercisable as follows: 970 shares on 2/24/2023 and 970 shares on 2/24/2024. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC |
Snodgres JonChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,047 | $0.00 Strike: $86.10 | $0.00 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · derivative · entry 5 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,524 Underlying: Common Stock · 3,047 shares Expires 2030-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1,524 shares vest and become exercisable on 2/27/2023. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC |
Snodgres JonChief Financial Officer
|
SaleCommon Stock | 2,400 | $253.16 | $607,584.00 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 4 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,506 Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC |
Snodgres JonChief Financial Officer
|
SaleCommon Stock | 4,298 | $252.70 | $1,086,104.60 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 3 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,906 F1 · price: $252.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.16 to $253.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC |
Snodgres JonChief Financial Officer
|
Exercise / conversionCommon Stock | 970 | $215.58 | $209,112.60 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 2 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 20:41 UTC |
Snodgres JonChief Financial Officer
|
Exercise / conversionCommon Stock | 3,047 | $86.10 | $262,346.70 |
DisclosureSEC source: 0000899243-22-028997 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:49 UTC |
KURIYEL RALFSenior VP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 646 | $0.00 Strike: $86.10 | $0.00 |
DisclosureSEC source: 0000899243-22-028506 · doc4.xml · derivative · entry 8 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 646 shares Expires 2027-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1,046 shares vest and become exercisable on 2/27/2023. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:49 UTC |
KURIYEL RALFSenior VP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,354 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0000899243-22-028506 · doc4.xml · derivative · entry 7 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,354 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:49 UTC |
KURIYEL RALFSenior VP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $33.05 | $0.00 |
DisclosureSEC source: 0000899243-22-028506 · doc4.xml · derivative · entry 6 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2026-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:49 UTC |
KURIYEL RALFSenior VP, R&D
|
SaleCommon Stock | 4,040 | $254.14 | $1,026,725.60 |
DisclosureSEC source: 0000899243-22-028506 · doc4.xml · nonDerivative · entry 5 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,270 F1 · price: $254.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.10 to $254.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:49 UTC |
KURIYEL RALFSenior VP, R&D
|
SaleCommon Stock | 800 | $255.20 | $204,160.00 |
DisclosureSEC source: 0000899243-22-028506 · doc4.xml · nonDerivative · entry 4 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,310 Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:49 UTC |
KURIYEL RALFSenior VP, R&D
|
Exercise / conversionCommon Stock | 646 | $86.10 | $55,620.60 |
DisclosureSEC source: 0000899243-22-028506 · doc4.xml · nonDerivative · entry 3 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:49 UTC |
KURIYEL RALFSenior VP, R&D
|
Exercise / conversionCommon Stock | 1,354 | $59.52 | $80,590.08 |
DisclosureSEC source: 0000899243-22-028506 · doc4.xml · nonDerivative · entry 2 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 20:49 UTC |
KURIYEL RALFSenior VP, R&D
|
Exercise / conversionCommon Stock | 2,000 | $33.05 | $66,100.00 |
DisclosureSEC source: 0000899243-22-028506 · doc4.xml · nonDerivative · entry 1 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 20:29 UTC |
Gebski ChristineSee Remarks
|
SaleCommon Stock | 3,357 | $243.01 | $815,784.57 |
DisclosureSEC source: 0000899243-22-027833 · doc4.xml · nonDerivative · entry 1 Gebski Christine · CIK 0001849585 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,735 F1 · price: $243.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.98 to $243.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 03, 2022 Filed Aug 4, 2022 20:32 UTC |
Bylund JamesChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $94.33 | $0.00 |
DisclosureSEC source: 0000899243-22-027710 · doc4.xml · derivative · entry 3 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 2,000 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 4,000 of the shares underlying the option have vested. The remaining shares vest as follows: 2,000 shares on April 1, 2023, April 1, 2024 and April 1, 2025. Read SEC document |
| August 03, 2022 Filed Aug 4, 2022 20:32 UTC |
Bylund JamesChief Operating Officer
|
SaleCommon Stock | 2,000 | $240.40 | $480,800.00 |
DisclosureSEC source: 0000899243-22-027710 · doc4.xml · nonDerivative · entry 2 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,733 F1 · price: $240.40 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.36 to $240.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 03, 2022 Filed Aug 4, 2022 20:32 UTC |
Bylund JamesChief Operating Officer
|
Exercise / conversionCommon Stock | 2,000 | $94.33 | $188,660.00 |
DisclosureSEC source: 0000899243-22-027710 · doc4.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 21:26 UTC |
Snodgres JonChief Financial Officer
|
SaleCommon Stock | 2,000 | $220.00 | $440,000.00 |
DisclosureSEC source: 0000899243-22-027415 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,187 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 9, 2022. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:25 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,154 | $0.00 Strike: $32.40 | $0.00 |
DisclosureSEC source: 0000899243-22-026581 · doc4.xml · derivative · entry 5 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,154 shares Expires 2027-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:25 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $33.87 | $0.00 |
DisclosureSEC source: 0000899243-22-026581 · doc4.xml · derivative · entry 4 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,246 Underlying: Common Stock · 5,000 shares Expires 2028-02-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:25 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
SaleCommon Stock | 24,802 | $200.00 | $4,960,400.00 |
DisclosureSEC source: 0000899243-22-026581 · doc4.xml · nonDerivative · entry 3 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,667 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:25 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 15,154 | $32.40 | $490,989.60 |
DisclosureSEC source: 0000899243-22-026581 · doc4.xml · nonDerivative · entry 2 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:25 UTC |
Hunt AnthonyDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 5,000 | $33.87 | $169,350.00 |
DisclosureSEC source: 0000899243-22-026581 · doc4.xml · nonDerivative · entry 1 Hunt Anthony · CIK 0001606030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:25 UTC |
Mhatre RohinDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,920 | $0.00 Strike: $159.17 | $0.00 |
DisclosureSEC source: 0000899243-22-020284 · doc4.xml · derivative · entry 2 Mhatre Rohin · CIK 0001798735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,920 Underlying: Common Stock · 2,920 shares Expires 2032-05-26 F2 · derivative.exercise_date: Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:25 UTC |
Mhatre RohinDirector
|
GrantCommon Stock | 1,202 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020284 · doc4.xml · nonDerivative · entry 1 Mhatre Rohin · CIK 0001798735 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,659 F1 · shares: Mr. Mhatre was awarded 1,202 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:23 UTC |
Konstantinov KonstantinDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,498 | $0.00 Strike: $159.17 | $0.00 |
DisclosureSEC source: 0000899243-22-020283 · doc4.xml · derivative · entry 3 Konstantinov Konstantin · CIK 0001774649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,498 Underlying: Common Stock · 2,498 shares Expires 2032-05-26 F3 · derivative.exercise_date: The shares vest in equal annual instalments over a three-year period with each such vesting date occurring on the earlier of the anniversary of the grant date or the date of the annual meeting of the Company's shareholders of the applicable year of such three-year period. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:23 UTC |
Konstantinov KonstantinDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,298 | $0.00 Strike: $159.17 | $0.00 |
DisclosureSEC source: 0000899243-22-020283 · doc4.xml · derivative · entry 2 Konstantinov Konstantin · CIK 0001774649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,298 Underlying: Common Stock · 1,298 shares Expires 2032-05-26 F2 · derivative.exercise_date: Award vests in full on May 26, 2023, one year from grant date. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:23 UTC |
Konstantinov KonstantinDirector
|
GrantCommon Stock | 534 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020283 · doc4.xml · nonDerivative · entry 1 Konstantinov Konstantin · CIK 0001774649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534 F1 · shares: Mr. Konstantinov was awarded 534 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 26, 2023, one year from the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:21 UTC |
DAWES KAREN ADirector
|
GrantStock Option (Right to Buy) · Derivative | 1,565 | $0.00 Strike: $159.17 | $0.00 |
DisclosureSEC source: 0000899243-22-020280 · doc4.xml · derivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,565 Underlying: Common Stock · 1,565 shares Expires 2032-05-26 F2 · derivative.exercise_date: Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:21 UTC |
DAWES KAREN ADirector
|
GrantCommon Stock | 644 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020280 · doc4.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,176 F1 · shares: Ms. Dawes was awarded 644 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:20 UTC |
BARTHELEMY NICOLASDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,298 | $0.00 Strike: $159.17 | $0.00 |
DisclosureSEC source: 0000899243-22-020279 · doc4.xml · derivative · entry 2 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,298 Underlying: Common Stock · 1,298 shares Expires 2032-05-26 F2 · derivative.exercise_date: Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:20 UTC |
BARTHELEMY NICOLASDirector
|
GrantCommon Stock | 534 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020279 · doc4.xml · nonDerivative · entry 1 BARTHELEMY NICOLAS · CIK 0001283576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,081 F1 · shares: Mr. Barthelemy was awarded 534 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:17 UTC |
MUIR GLENN PDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,298 | $0.00 Strike: $159.17 | $0.00 |
DisclosureSEC source: 0000899243-22-020276 · doc4.xml · derivative · entry 2 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,298 Underlying: Common Stock · 1,298 shares Expires 2032-05-26 F2 · derivative.exercise_date: Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:17 UTC |
MUIR GLENN PDirector
|
GrantCommon Stock | 534 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020276 · doc4.xml · nonDerivative · entry 1 MUIR GLENN P · CIK 0001181190 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,896 F1 · shares: Mr. Muir was awarded 534 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:15 UTC |
EGLINTON MANNER CARRIEDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,488 | $0.00 Strike: $159.17 | $0.00 |
DisclosureSEC source: 0000899243-22-020272 · doc4.xml · derivative · entry 2 EGLINTON MANNER CARRIE · CIK 0001696776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,488 Underlying: Common Stock · 2,488 shares Expires 2032-05-26 F2 · derivative.exercise_date: Award vests in full on the earlier of May 26, 2023, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined. Read SEC document |
| May 26, 2022 Filed Jun 1, 2022 00:15 UTC |
EGLINTON MANNER CARRIEDirector
|
GrantCommon Stock | 1,024 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020272 · doc4.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,481 F1 · shares: Ms. Eglinton Manner was awarded 1,024 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 26, 2023, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:17 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 742 | $152.84 | $113,407.28 |
DisclosureSEC source: 0000899243-22-019772 · doc4.xml · nonDerivative · entry 5 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,532 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F6 · price: $152.84 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.69 to $153.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:17 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 1,875 | $152.14 | $285,262.50 |
DisclosureSEC source: 0000899243-22-019772 · doc4.xml · nonDerivative · entry 4 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,274 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F5 · price: $152.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.63 to $152.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:17 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 1,845 | $151.14 | $278,853.30 |
DisclosureSEC source: 0000899243-22-019772 · doc4.xml · nonDerivative · entry 3 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,149 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F4 · price: $151.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.63 to $151.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:17 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 7,677 | $150.19 | $1,153,008.63 |
DisclosureSEC source: 0000899243-22-019772 · doc4.xml · nonDerivative · entry 2 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,994 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F3 · price: $150.19 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.62 to $150.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:17 UTC |
DAWES KAREN ADirector
|
SaleCommon Stock | 2,576 | $149.18 | $384,287.68 |
DisclosureSEC source: 0000899243-22-019772 · doc4.xml · nonDerivative · entry 1 DAWES KAREN A · CIK 0001261506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,671 F1 · kind: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on June 8, 2021. F2 · price: $149.18 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.61 to $149.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 13, 2022 Filed May 17, 2022 21:00 UTC |
KURIYEL RALFSenior VP, R&D
|
Tax withholdingCommon Stock | 712 | $150.40 | $107,084.80 |
DisclosureSEC source: 0000899243-22-018418 · doc4.xml · nonDerivative · entry 1 KURIYEL RALF · CIK 0001733143 · Senior VP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,110 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:59 UTC |
Snodgres JonChief Financial Officer
|
Tax withholdingCommon Stock | 712 | $150.40 | $107,084.80 |
DisclosureSEC source: 0000899243-22-018416 · doc4.xml · nonDerivative · entry 1 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,187 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:59 UTC |
Gebski ChristineSee Remarks
|
Tax withholdingCommon Stock | 335 | $150.40 | $50,384.00 |
DisclosureSEC source: 0000899243-22-018417 · doc4.xml · nonDerivative · entry 1 Gebski Christine · CIK 0001849585 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,092 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 21:57 UTC |
Bylund JamesChief Operating Officer
|
Tax withholdingCommon Stock | 335 | $188.02 | $62,986.70 |
DisclosureSEC source: 0000899243-22-013421 · doc4.xml · nonDerivative · entry 1 Bylund James · CIK 0001849642 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,733 F1 · shares: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units. Read SEC document |
| March 16, 2022 Filed Dec 15, 2022 11:55 UTC |
EGLINTON MANNER CARRIEDirector
|
PurchaseCommon Stock | 625 | $175.02 | $109,387.50 |
DisclosureSEC source: 0000899243-22-038565 · doc4.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,106 Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 01:02 UTC |
Snodgres JonChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,214 | $0.00 Strike: $59.52 | $0.00 |
DisclosureSEC source: 0000899243-22-010327 · doc4.xml · derivative · entry 4 Snodgres Jon · CIK 0001613498 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,574 Underlying: Common Stock · 1,214 shares Expires 2029-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.